Company / R&D per Share
uniQure N.V. R&D per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.96
FY2024
5-year range
$2.75 / $4.51
FY2020-FY2024
Trend
-34.4%
vs FY2023
Sector context
#71 of 208
Health Care
What the data says
At $2.96, uniQure N.V.'s r&d per share ranks #71 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $2.10 in FY2018 to $4.51 in FY2023.
Based on SEC 10-K filings.
2.96 in FY2024 with a 5-year CAGR of +4.5%.
Declined from $4.23 to $2.96 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
#71 of 208 in Health CareTop 34% of 208This company $2.96 Sector average $28.82
▼
-89.7% below sector average
Key checks
Key Insights
- In FY2024, r&d per share decreased 34.4% year-over-year.
- Ranks #71 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.96 | -34.4% |
| FY2023 | $4.51 | +6.6% |
| FY2022 | $4.23 | +38.0% |
| FY2021 | $3.06 | +11.3% |
| FY2020 | $2.75 | +16.2% |
| FY2019 | $2.37 | +12.8% |
| FY2018 | $2.10 | -26.5% |
| FY2017 | $2.86 | -4.1% |
| FY2016 | $2.98 | +11.3% |
| FY2015 | $2.68 | +4.7% |
As of FY2024 · SEC Form 10-K · Last checked Jul 3, 2026